ArticleInnovation (Cambridge (Mass.))2026
Direct mapping of neural activity via glutamate-weighted magnetic resonance imaging.
Article in Innovation (Cambridge (Mass.)), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Conventional functional magnetic resonance imaging (fMRI) indirectly maps neural activity via blood oxygenation level-dependent (BOLD) contrast. Directly probing glutamate, the primary excitatory neurotransmitter, during task-related stimulation offers a more precise neuroimaging approach. Chemical exchange saturation transfer (CEST), a molecular MRI technique, can provide insights into brain metabolites, including glutamate. While prior studies have attempted to apply CEST in fMRI contexts-either to detect glucose consumption in rats or to probe pH changes in the human brain (with the latter failing to detect significant changes)-none of these efforts successfully addressed the confounding influence of BOLD signal fluctuations on the acquired CEST contrast during task activation. Furthermore, to date, no study has reported task-evoked activation maps based on dynamic glutamate changes detected by CEST-MRI. Here, we are the first to propose and implement a dynamic signal model that integrates both BOLD and CEST effects. Derived from the analysis of temporal response amplitude, we introduce a metric potentially detecting changes in glutamate concentration during neural activity, along with corresponding glutamate-weighted activation maps. Simulation results based on this model show strong agreement with experimental results during block design visual tasks in the human brain on a 3 Tesla scanner, but only when incorporating increased glutamate concentration during the stimulation state. Furthermore, the glutamate-weighted activation maps obtained in our experiments demonstrate a more precise localization of visual cortex regions compared with the classical BOLD contrast activation maps. Our findings provide a potential explanation for the mechanism underlying CEST-fMRI and underscore the potential of this imaging modality to directly map neural activity by leveraging glutamate concentration detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.